Publications by authors named "A Csillag"

Article Synopsis
  • Gestational exposure to valproic acid (VPA) in rodents creates a model that reflects behavioral deficits seen in human autism spectrum disorder (ASD), particularly reduced sociability.
  • Previous studies indicated that VPA treatment resulted in specific changes in the brain's dopaminergic pathways, particularly affecting dopamine levels in certain areas but not others.
  • The latest research used advanced imaging techniques to analyze the connections between dopaminergic axons and specific neuronal markers in key brain regions, revealing reduced synaptic interactions and changes in neuron populations in VPA treated mice.
View Article and Find Full Text PDF

Gestational exposure of mice to valproic acid (VPA) is one currently used experimental model for the investigation of typical failure symptoms associated with autism spectrum disorder (ASD). In the present study we hypothesized that the reduction of dopaminergic source neurons of the VTA, followed by perturbed growth of the mesotelencephalic dopamine pathway (MT), should also modify pattern formation in the dopaminoceptive target regions (particularly its mesoaccumbens/mesolimbic portion). Here, we investigated VPA-evoked cellular morphological (apoptosis-frequency detected by Caspase-3, abundance of Ca-binding proteins, CaBP), as well as synaptic proteomic (western blotting) changes, in selected dopaminoceptive subpallial, as compared to pallial, regions of mice, born to mothers treated with 500 mg/kg VPA on day 13.

View Article and Find Full Text PDF

The current review is an update on experimental approaches in which birds serve as model species for the investigation of typical failure symptoms associated with autism spectrum disorder (ASD). The discussion is focused on deficiencies of social behavior, from social interactions of domestic chicks, based on visual and auditory cues, to vocal communication in songbirds. Two groups of pathogenetic/risk factors are discussed: 1) non-genetic (environmental/epigenetic) factors, exemplified by embryonic exposure to valproic acid (VPA), and 2) genetic factors, represented by a list of candidate genes and signaling pathways of diagnostic or predictive value in ASD patients.

View Article and Find Full Text PDF